Bupropion Tablet, Extended Release
Product Images NDC 63187-521

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion (NDC 63187-521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion Hydrochloride Extended-release Tablets, Usp (xl) (Bupropionxltablets Figure 01)

FDA Label Image

Image 01

Image 01
This is a description of a prescription medication called Bupropion HCI 300mg (Once Daily), manufactured by Cadila Healthcare Limited in Ahmedabad, India. The medication comes in the form of 30 XL tablets, each containing 300mg of Bupropion hydrochloride, and is intended for RX use only. The tablets are round, biconvex, and coated in a creamy-white to pale-yellow color. They are imprinted with the number "354" in black ink on one side and plain on the other. The medication comes with a warning not to be used in combination with other medicines that contain bupropion hydrochloride, including ZYBAN. The lot number is 00000, and the expiration date is 00/00/00. The medication should be stored at 20°-25°C (68°-77°F) and kept out of the reach of children. The medication guide should be provided separately to each patient. The medication has been relabeled by Proficient Rx LP in Thousand Oaks, CA 91320.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.